PYXIS ONCOLOGY INC (PYXS:NASDAQ)

$3.27 -0.11 (-3.2544%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 69

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed PYXIS ONCOLOGY INC (PYXS:NASDAQ) News Sources

Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026

17-04-2026

yahoo.com

Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer

07-05-2026

yahoo.com

Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

14-05-2026

yahoo.com

Pyxis Oncology Secures Up to $114 Million Private Placement

30-06-2026

yahoo.com

Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

13-08-2026

yahoo.com

Pyxis Oncology to Participate in Upcoming Investor Conferences

01-09-2026

yahoo.com

Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board

08-09-2026

yahoo.com

Pyxis Oncology to Host Webcast to Present Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)

08-09-2026

yahoo.com

Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)

09-09-2026

yahoo.com

Pyxis Oncology shares fall 7% despite updated MICVO trial results

09-09-2026

advfn.com

PYXIS ONCOLOGY INC (PYXS:NASDAQ) Sentiment Trend

0 25 50 75 100 20 76 65 89 78 79 77 65 54 84 17-04-2026 07-05-2026 14-05-2026 30-06-2026 13-08-2026 01-09-2026 08-09-2026 09-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

PYXIS ONCOLOGY INC (PYXS:NASDAQ) FAQs

toggle

What is the current price of PYXIS ONCOLOGY INC (PYXS:NASDAQ)?

The current price of PYXIS ONCOLOGY INC (PYXS:NASDAQ) is $3.27.


toggle

PYXIS ONCOLOGY INC (PYXS:NASDAQ) absolute price change since previous trading day?

The absolute price change of PYXIS ONCOLOGY INC (PYXS:NASDAQ) since the previous trading day is $-0.11.


toggle

PYXIS ONCOLOGY INC (PYXS:NASDAQ) percentage price change since previous trading day?

The percentage price change of PYXIS ONCOLOGY INC (PYXS:NASDAQ) since the previous trading day is -3.2544%.


toggle

What is the most recent average sentiment score for PYXIS ONCOLOGY INC (PYXS:NASDAQ)?

The most recent average sentiment score for PYXIS ONCOLOGY INC (PYXS:NASDAQ) is 69 out of 100.


toggle

What is the most recent average sentiment for PYXIS ONCOLOGY INC (PYXS:NASDAQ)?

The most recent sentiment for PYXIS ONCOLOGY INC (PYXS:NASDAQ) is .


SEC-8K** Filing Available For PYXIS ONCOLOGY INC (PYXS:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.